文献速递神经核医学肿瘤 PET/CT

帕金森病脑葡萄糖代谢异常模式:三个欧洲队列的重复验证

Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-11-25

该研究对荷兰、意大利和西班牙三个帕金森病(PD)队列进行18F-FDG PET空间协方差分析,识别出PD相关脑代谢模式(PDRP),表现为丘脑、壳核/苍白球、脑桥、小脑和运动皮质相对高代谢,伴后顶叶、枕叶和额叶皮质不同程度低代谢。各中心PDRP在验证队列中均显著表达(P < 0.0001),交叉验证仍显著(P < 0.005),且在多系统萎缩中不表达。

要点

  • PDRP是跨欧洲PD队列可重复的脑代谢特征。
  • PDRP表达在PD患者中显著,交叉验证保持显著。
  • PDRP在多系统萎缩中不表达。

核心结论

  • PDRP是可跨PD人群和扫描平台重复的疾病特征。

研究设计与样本

  • 荷兰队列:17名对照和19名PD识别PDRP,19名健康对照和20名PD验证表达。
  • 意大利队列:20名对照和20名新发PD识别PDRP,24名对照和18名新发PD验证。
  • 三中心模式视觉比较并交叉验证,另在8名多系统萎缩患者中测定PDRP表达。

主要发现

  • 每个队列均识别出PDRP,特征为丘脑、壳核/苍白球、脑桥、小脑和运动皮质相对高代谢,伴后顶叶、枕叶和额叶皮质不同程度低代谢。
  • 新发PD(意大利队列)额叶低代谢较轻,晚期PD(西班牙队列)枕叶低代谢更明显。
  • 验证队列中PD患者PDRP表达显著高于对照(P < 0.0001),交叉验证仍显著(P < 0.005)。
  • 8名多系统萎缩患者中PDRP表达缺失。

关键数值与推荐

  • PDRP在荷兰验证队列PD患者中显著表达(P < 0.0001),交叉验证显著(P < 0.005)。
  • PDRP在意大利验证队列PD患者中显著表达(P < 0.0001),交叉验证显著(P < 0.005)。
  • PDRP在西班牙验证队列PD患者中显著表达(P < 0.0001),交叉验证显著(P < 0.005)。

临床怎么用

  • PDRP表达可客观评估PD个体疾病活动,并有助于鉴别多系统萎缩。
  • 解读PDRP时需考虑病程亚型差异和中心特异性效应。

局限性

  • 需进一步研究明确特定PD亚型的拓扑特征,并识别和校正中心特异性效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: In Parkinson's disease (PD), spatial covariance analysis of 18F-FDG PET data has consistently revealed a characteristic PD-related brain pattern (PDRP). By quantifying PDRP expression on a scan-by-scan basis, this technique allows objective assessment of disease activity in individual subjects. We provide a further validation of the PDRP by applying spatial covariance analysis to PD cohorts from the Netherlands (NL), Italy (IT), and Spain (SP). METHODS: The PDRPNL was previously identified (17 controls, 19 PD) and its expression was determined in 19 healthy controls and 20 PD patients from the Netherlands. The PDRPIT was identified in 20 controls and 20 "de-novo" PD patients from an Italian cohort. A further 24 controls and 18 "de-novo" Italian patients were used for validation. The PDRPSP was identified in 19 controls and 19 PD patients from a Spanish cohort with late-stage PD. Thirty Spanish PD patients were used for validation. Patterns of the three centers were visually compared and then cross-validated. Furthermore, PDRP expression was determined in 8 patients with multiple system atrophy. RESULTS: A PDRP could be identified in each cohort. Each PDRP was characterized by relative hypermetabolism in the thalamus, putamen/pallidum, pons, cerebellum, and motor cortex. These changes co-varied with variable degrees of hypometabolism in posterior parietal, occipital, and frontal cortices. Frontal hypometabolism was less pronounced in "de-novo" PD subjects (Italian cohort). Occipital hypometabolism was more pronounced in late-stage PD subjects (Spanish cohort). PDRPIT, PDRPNL, and PDRPSP were significantly expressed in PD patients compared with controls in validation cohorts from the same center (P < 0.0001), and maintained significance on cross-validation (P < 0.005). PDRP expression was absent in MSA. CONCLUSION: The PDRP is a reproducible disease characteristic across PD populations and scanning platforms globally. Further study is needed to identify the topography of specific PD subtypes, and to identify and correct for center-specific effects.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Meles SK, Renken RJ, Pagani M, et al. Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts. Eur J Nucl Med Mol Imaging. 2019. PMID: 31768600. doi:10.1007/s00259-019-04570-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。